PHOENIX BIOTECH ACQUISITION CORP. Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Description of Securities (Filed With SEC on October 21, 2024)
- Offer Letter, dated as of March 28, 2024, by and between CERo Therapeutics Holdings, Inc. and Daniel Corey (Filed With SEC on April 2, 2024)
- Description of Securities (Filed With SEC on April 2, 2024)
- Side Letter, dated as of February 14, 2024, by and between Phoenix Biotech Acquisition Corp. and the Lead Investor (Filed With SEC on February 27, 2024)
- Letter Agreement, dated as of February 14, 2024, by and between Phoenix Biotech Sponsor, LLC and Cero Therapeutics Holdings, Inc (Filed With SEC on February 27, 2024)
- Description of Securities (Filed With SEC on February 27, 2024)
- Form of CERo Support Agreement (Filed With SEC on June 5, 2023)
- Form of Sponsor Support Agreement (Filed With SEC on June 5, 2023)
- Phoenix Biotech Acquisition Corp. Description of Securities (Filed With SEC on March 24, 2022)
- Form of Engagement Letter with Cohen & Company Capital Markets (Filed With SEC on September 28, 2021)
- Specimen Unit Certificate (Filed With SEC on September 21, 2021)
- Form of Indemnity Agreement (Filed With SEC on September 13, 2021)
- Specimen Unit Certificate (Filed With SEC on September 13, 2021)